Akinori Nukui

Dokkyo Medical University

Papers

1

Total Citations

12

H-Index

1

About

Dr. Akinori Nukui is a distinguished urologic surgeon and researcher whose work centers on improving oncological outcomes for prostate cancer patients, particularly those with intermediate to high-risk disease. His major contributions lie in refining predictive models that integrate prostate-specific antigen density (PSAD) with detailed biopsy core characteristics—such as the number and location of positive cores—to better forecast biochemical recurrence and disease progression following robot-assisted radical prostatectomy. This research, exemplified by his highly cited 2017 study (12 citations), provides clinicians with practical tools to tailor surgical extent and lymph node dissection, moving beyond traditional risk stratification. Dr. Nukui’s work has been instrumental in bridging the gap between pathological findings and personalized surgical decision-making, directly impacting patient counseling and postoperative management. His findings underscore the value of combining serum biomarkers with histopathological details, offering a more nuanced approach to predicting outcomes in a challenging patient population. Through these efforts, Dr. Nukui has advanced the precision of prostate cancer care, making his research a key reference for urologists and oncologists seeking to optimize treatment strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy
12 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Dokkyo Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago